How to Save Money on Sandostatin in 2026: Coupons, Discounts, and Patient Assistance

Sandostatin LAR Depot — the once-monthly injection most patients rely on for long-term management — carries a retail price of $6,700 to $8,500 per monthly injection. Without help, that's one of the most expensive specialty medications you can be prescribed. But there are multiple programs designed to bring that cost down significantly, often to $0 for eligible patients.

Here is a complete breakdown of every savings option available for Sandostatin and generic octreotide in 2026.

What Does Sandostatin Actually Cost?

Before diving into savings options, here are the cash prices by formulation:

• Generic immediate-release octreotide injection: $40–$110 for 10 vials (100 mcg/mL) at retail. As low as $41 with a SingleCare coupon or $89 with GoodRx.
• Sandostatin LAR Depot (brand, Novartis): $6,700–$8,500 per monthly injection at retail. With GoodRx coupon: as low as $1,149 at select pharmacies.
• Generic octreotide LAR (Teva): $3,000–$5,500 per monthly injection — approximately 40–50% less than brand Sandostatin LAR.
• Mycapssa (oral octreotide): $8,000–$10,000 per month.

Option 1: Novartis Copay Assistance Card (Commercially Insured Patients)

If you have commercial (private or employer-sponsored) insurance and take Sandostatin LAR Depot, the Novartis copay assistance card is by far the most powerful savings option available. It can cover up to $15,000 per calendar year in out-of-pocket costs.

With this card, many commercially insured patients pay $0 out of pocket per month for their Sandostatin LAR injection.

How to get it: Call Novartis Patient Support at 1-800-277-2254, or ask your specialty pharmacy to enroll you at the time of dispensing. Many specialty pharmacies automatically apply the copay card.

Who qualifies: Commercially insured patients (not Medicare or Medicaid). Must have an active Sandostatin prescription for an FDA-approved indication.

Option 2: Novartis Patient Assistance Foundation (Uninsured or Underinsured Patients)

If you don't have insurance or can't afford your medication even with insurance, the Novartis Patient Assistance Foundation may provide Sandostatin at no cost to you.

Who qualifies: U.S. residents with a valid prescription who are uninsured or underinsured and meet income criteria (typically 400–500% of the federal poverty level). Patients on Medicare or Medicaid may also qualify if they meet income thresholds.

How to apply: Applications are processed through your doctor's office. Once approved, medication is typically shipped directly to your provider or home. Call 1-800-277-2254 for more information.

Option 3: Prescription Discount Cards (Immediate-Release Octreotide)

Prescription discount cards like GoodRx and SingleCare are most impactful for the immediate-release octreotide injection. They can reduce the retail price by up to 80–87%:

• GoodRx: Generic octreotide injection available for as low as $88–$89 (87% off retail of ~$685).
• SingleCare: Prices as low as $41.21 for 10 vials of 100 mcg/mL. No membership required.
• For Sandostatin LAR Depot: GoodRx shows prices starting around $1,149 with their coupon — a significant reduction from the $6,900+ retail price — but still very expensive. For the LAR formulation, the Novartis copay card or a patient assistance program will almost always provide better savings than a discount card.

Important: Prescription discount cards generally cannot be used in combination with insurance. They are best used when you are uninsured or when the discount card price is lower than your insurance copay.

Option 4: Independent Foundations for Copay Assistance

Several nonprofit foundations provide copay assistance for patients with neuroendocrine tumors and acromegaly:

• Patient Access Network (PAN) Foundation: Offers copay assistance for neuroendocrine tumor patients when funds are available. Covers copays, coinsurance, and deductibles. Check their website for current fund availability — funds open and close throughout the year.
• HealthWell Foundation: Sometimes offers programs for acromegaly or neuroendocrine tumor patients. Grants can cover copays and, in some cases, insurance premiums.

Option 5: Switch to Generic Octreotide LAR

If you're taking brand Sandostatin LAR Depot, ask your doctor about switching to Teva's generic octreotide LAR (FDA-approved October 2024) or Viatris's generic. Generic octreotide LAR costs $3,000–$5,500 per month — 40–50% less than the brand. This is particularly relevant if your insurance doesn't have a copay assistance program available or if you're paying a significant portion out of pocket.

Option 6: Medicare and Medicaid Coverage

On Medicare Part D, octreotide is typically placed on Tier 4 (specialty tier). Your cost-sharing will depend on your specific plan and whether you've met your deductible. During the catastrophic coverage phase, your costs are capped. If you have Medicare and are having difficulty affording Sandostatin, ask your doctor about the Novartis Patient Assistance Foundation — many Medicare patients with insufficient income qualify.

Medicaid coverage varies by state and formulary. Contact your state Medicaid program directly to verify coverage.

Bottom Line: What's the Best Option for Me?

Here's a quick guide:

• Commercially insured: Apply for the Novartis copay card (up to $15,000/year). Most patients pay $0/month.
• Uninsured or underinsured: Apply for the Novartis Patient Assistance Foundation. Consider PAN Foundation or HealthWell Foundation. Use discount cards for immediate-release octreotide if you're bridging.
• Medicare: Manufacturer copay cards can't be used with Medicare. Apply for the Novartis Patient Assistance Foundation if income criteria are met, or the PAN Foundation.

Cost is one barrier — finding the medication in stock is another. If you need help locating a pharmacy with Sandostatin available, medfinder can help find pharmacies near you that can fill your prescription.